ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Vontobel Financial Products GmbH

Vontobel Financial Products GmbH (F16424)

0.00
0.00
( 0.00% )

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

F16424 Latest News

Déclaration des transactions sur actions propres réalisées le 31 juillet 2024

Déclaration des transactions sur actions propres réalisées le 31 juillet 2024 La déclaration des transactions sur actions propres réalisées le 31 juillet 2024 est disponible ici sur www.scor.com...

Déclaration au titre de l’article L. 233-8 II du Code de Commerce et de l’article 223-16 du Règlement général de l’Autorité des marchés financiers

Déclaration au titre de l’article L. 233-8 II du Code de Commerce et de l’article 223-16 du Règlement général de l’Autorité des marchés financiers Information1 août 2024 Déclaration au titre de...

Declaration made pursuant to Article L. 233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers

Declaration made pursuant to Article L. 233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers InformationAugust 1, 2024...

SCOR announces the publication of its interim financial report for the six months ended June 30, 2024

SCOR announces the publication of its interim financial report for the six months ended June 30, 2024 Press releaseJuly 31, 2024 - N° 12 SCOR announces the publication of its interim financial...

SCOR annonce la publication de son rapport financier semestriel au 30 juin 2024

SCOR annonce la publication de son rapport financier semestriel au 30 juin 2024 Communiqué de presse31 juillet 2024 - N° 12    SCOR annonce la publication de son rapportfinancier semestriel au 30...

Second quarter 2024 results: Despite very strong P&C results and Investments performances, SCOR posts a EUR -308 million net loss in Q2 2024 (EUR -112 million net loss in H1 2024), driven by the 2024 L&H assumption review

Second quarter 2024 results: Despite very strong P&C results and Investments performances, SCOR posts a EUR -308 million net loss in Q2 2024 (EUR -112 million net loss in H1 2024), driven by...

Résultats T2 2024 : Malgré une très forte performance de P&C et du portefeuille d’investissement, SCOR publie une perte nette de €-308 millions au T2 2024 (perte nette de €-112 millions pour S1 2024), due à la revue 2024 des hypothèses L&H

Résultats T2 2024 : Malgré une très forte performance de P&C et du portefeuille d’investissement, SCOR publie une perte nette de €-308 millions au T2 2024 (perte nette de €-112 millions pour...

Second quarter 2024 results: Despite very strong P&C results and Investments performances, SCOR posts a EUR -308 million net loss in Q2 2024 (EUR -112 million net loss in H1 2024), driven by the 2024 L&H assumption review

Second quarter 2024 results                 Despite very strong P&C results and Investments performances, SCOR posts a EUR -308 million net loss in Q2 2024 (EUR -112 million net loss in H1...

SCOR informe sur ses résultats du deuxième trimestre 2024 et de l’année 2024

SCOR informe sur ses résultats du deuxième trimestre 2024 et de l’année 2024 Communiqué de presse15 juillet 2024 - N° 10 SCOR informe sur ses résultats du deuxième trimestre 2024 et de l’année...

SCOR provides an update on its Q2 2024 and FY 2024 results

Press release15 July 2024 - N° 10 SCOR provides an update on its Q2 2024 and FY 2024 results Following the negative experience variance in the first quarter of 2024, SCOR has decided to accelerate...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
REVBRevelation Biosciences Inc
$ 2.50
(140.76%)
7.19M
SDIGStronghold Digital Mining Inc
$ 4.43
(51.19%)
1.92M
WENAANEW MEDICAL INC
$ 1.39
(34.95%)
11.11M
PAVMPAVmed Inc
$ 0.90
(28.57%)
25
CUBAHerzfeld Caribbean Basin Fund Inc
$ 2.80
(23.89%)
85
EYENEyenovia Inc
$ 0.43
(-36.78%)
399.3k
STECSantech Holdings Limited
$ 0.2954
(-31.30%)
346.45k
AADIAadi Bioscience Inc
$ 1.19
(-26.54%)
4.15k
MYNAMynaric AG
$ 1.35
(-26.23%)
146k
APDNApplied DNA Sciences Inc
$ 1.15
(-25.32%)
622.72k
OBLGOblong Inc
$ 0.1232
(15.46%)
25.33M
ZCARZoomcar Holdings Inc
$ 0.1753
(16.48%)
15.7M
WENAANEW MEDICAL INC
$ 1.39
(34.95%)
11.11M
GLMDGalmed Pharmaceuticals Ltd
$ 0.3388
(12.22%)
9.16M
REVBRevelation Biosciences Inc
$ 2.49
(139.79%)
7.19M

Discussion

View Full Feed
art2426 art2426 38 seconds ago
"pounding away" --- LMAO, why would I not, with all this laughable praise of a company and leadership that has never shown profit in over twenty years and has rewarded those that praise her, with a LOW triple zero stock price? Where are you going to find entertainment like that?

Bu
BIEL
prototype_101 prototype_101 51 seconds ago
Dice, watch again carefully when Yu says TFLN was the talk of the show the look on his face was more one of laughing mockery than of TFLN being taken seriously by him, I believe it is simply a case of TFLN being worked on by a number of companies now VERY similar to when Polymers would have been the
LWLG
StayHumble StayHumble 2 minutes ago
✅$DBMM🔥Ground Floor Investment🔥$GME|$AMC Level
$DBMM @dbmm_group
Positioned to disrupt multitrillion-dollar global market
Ground-floor investment opportunity
Comparisons to $GME and $AMC https://twitter.com/dbmm_group/status/1687191420178
AMC DBMM GME
TrendTrade2016 TrendTrade2016 2 minutes ago
CVKD 8 BUCKS COMING TO TOWN
CVKD
Semperfiguy Semperfiguy 3 minutes ago
I forgot about the smaller contract being fulfilled via ADS. Cyberlux already has an existing relationship with another very large GSA supplier they could shift to IF there was a disagreement with HII voiding the partnership.
CYBL
glens0 glens0 3 minutes ago
https://www.youtube.com/watch?v=78tQeCeVn_k
CEOS
linkvest linkvest 3 minutes ago
Really depends on how much you are planning to buy. Yesterday I bought 2m more shares at the 33s. After I bought of course it dropped even further to 31s LOL... But I really don't care about a couple hundred dollars as much as securing 2 million share this low. If your going to buy a million shares
IGPK
koldkash koldkash 3 minutes ago
REVB 2.91
REVB
makingmoneyx3 makingmoneyx3 4 minutes ago
Absolutely no evidence of CEO pump or bogus orders. How can people just make things up to post of the board. Just WOW
TXTM
rstar rstar 4 minutes ago
the sinister part of the story has been laid out in the facts presented by the SEC -affirmed by the court of appeals allowing Dale's assets to be seized. Dale and Cameron destroyed and disappeared your investment- by not disclosing FDA comments and lying- faking- promoting the possibility of EUA-des
iclight iclight 4 minutes ago
whatever makes you feel better about your shitty .35c investment. I don't need to get paid to take pleasure in pointing out worshippers of a .35c scam are idiots. I'll gladly do it for free.
NWBO
theorysuit theorysuit 5 minutes ago
Love to talk about paid fud. But i'm sure as hell there are a LOT of paid pumpers here. Why would anyone waste their time shorting a .34 stock....they want a few pennies? This fudster and MM talk is just straight up nonsense. This company underperforms in price because they haven't done jack
NWBO
bigone bigone 5 minutes ago
Good to hear from you. It seems to have been a while. Thanks for the update.
ABMBF
glens0 glens0 5 minutes ago
https://x.com/VetCommUS/status/1825957257382867148
CEOS
makingmoneyx3 makingmoneyx3 5 minutes ago
None of this is true or factual information.
TXTM
zab zab 6 minutes ago
Trump had no one speak at his convention, any past republican president's or vice president's, or any from his last administration.
$Parabolic2030?$ $Parabolic2030?$ 8 minutes ago
Audited company: Exactly

And this trash is worth .001 a share

Do you GET IT ?

Lmfaol. 😂😂
TXTM
Monksdream Monksdream 9 minutes ago
Moomoo session mayhem what if any will grow legs after 7:00
https://ih.advfn.com/markets/nasdaq/premarket
Tom turtles Tom turtles 10 minutes ago
Back to .31 already...wow.
INM
uranium-pinto-beans uranium-pinto-beans 11 minutes ago
TransMedics initiated with a Buy at Needham
Needham analyst Mike Matson initiated coverage of TransMedics with a Buy rating and $208 price target. The company's Organ Care System is supported by extensive clinical data and multiple FDA approvals and is enabling TransMedics to revolutionize th
TrendTrade2016 TrendTrade2016 12 minutes ago
stock is going nowhere...weekly is a disaster...watch and learn...clown dance will not work
IDVV
 just Scottie just Scottie 12 minutes ago
Me too
SONX

Your Recent History

Delayed Upgrade Clock